Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

How Expensive Is Abbott Laboratories Stock Right Now?
Motley Fool
Saturday, September 11, 2010 - 11:33am
tags:
Abbott Laboratories, investors
U.S. Court of Appeals Reverses Third-Party Payor Class Certification Suit Against Lilly
Yahoo/PR NewsWire
Saturday, September 11, 2010 - 11:32am
tags:
Eli Lilly, legal
Brain Cancer Drug Appeal Could Impact Merck, Teva
Seeking Alpha
Saturday, September 11, 2010 - 11:30am
tags:
Merck, Teva Pharmaceuticals, brain cancer, Temodar
FDA Approves New Dosing for FASLODEX® (fulvestrant) Injection in Treatment of Metastatic Breast Cancer in HR+ Postmenopausal Women
Yahoo/PR NewsWire
Saturday, September 11, 2010 - 11:28am
tags:
Faslodex, .breast cancer, AstraZeneca
Genzyme to cut 8% of global workforce: reports
Marketwatch
Friday, September 10, 2010 - 6:15pm
tags:
layoffs, Genzyme, Sanofi, M&A
Four Biotech Takeout Candidates
Forbes
Friday, September 10, 2010 - 11:57am
tags:
biotech, ViroPharma, Geron, Pharmacyclics, Allos, M&A
J&J unblinds cancer drug study on effectiveness
Yahoo/AP
Friday, September 10, 2010 - 11:55am
tags:
prostate cancer, JNJ
MedImmune Bets Its Fate on “Biobetters”
PharmExec
Friday, September 10, 2010 - 11:21am
tags:
MedImmune, AstraZeneca, biosimilars
Savient: Drug Approval or Another Delay?
TheStreet.com
Friday, September 10, 2010 - 11:15am
tags:
Savient, Krystexxa, gout
Yet Another Reason That Sanofi-Genzyme Deal Will Go Through
BNET Pharma
Friday, September 10, 2010 - 11:10am
tags:
M&A, Sanofi, Genzyme, teriflunomide, MS, Campath, multiple sclerosis
Bristol-Myers starts tender offer for ZymoGenetics
Yahoo/AP
Friday, September 10, 2010 - 11:09am
tags:
ZymoGenetics, M&A, Bristol-Myers Squibb
J&J Prostate Cancer Drug Boosts Survival
TheStreet.com
Friday, September 10, 2010 - 11:07am
tags:
JNJ, prostate cancer, abiraterone, Dendreon, Provenge
Watson Pharmaceuticals Inc. Jumps to 52-Week High
Learning Markets
Friday, September 10, 2010 - 9:41am
tags:
Watson Pharmaceuticals, generics
The One Thing You Must Know About Amgen
Motley Fool
Friday, September 10, 2010 - 9:33am
tags:
Amgen, Kevin Sharer, Pharma CEOs
Arena Pharma Will Fail: Hedge Fund Poll
TheStreet.com
Friday, September 10, 2010 - 9:32am
tags:
Arena Pharmaceuticals, obesity, Vivus, Qnexa, Contrave, Orexigen
Santarus licenses approved diabetes drug for $5M
Yahoo/AP
Friday, September 10, 2010 - 9:29am
tags:
Santarus, diabetes, Cycloset, Depomed, Glumetza
Alnylam Evenly Poised
Yahoo/Zacks.com
Friday, September 10, 2010 - 8:15am
tags:
Alnylam, Novartis, Biogen Idec, Roche, Isis Pharmaceuticals, Cubist Pharmaceuticals, Takeda, earnings
The One Thing to Know About Eli Lilly
Motley Fool
Friday, September 10, 2010 - 8:13am
tags:
Eli Lilly, Pharma CEOs, John Lechleiter
Abbott Labs Might Be Cheaper Than You Think
Motley Fool
Friday, September 10, 2010 - 8:11am
tags:
Abbott Laboratories
Stem-Cell Research Ban Suspended by Appeals Court
Bloomberg
Thursday, September 9, 2010 - 5:52pm
tags:
stem cells

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.